Guardian Capital Advisors LP Abb Vie Inc. Transaction History

Guardian Capital Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $47,025 - $56,395	-340 Reduced 19.1%	1,440 $232,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $234,924 - $291,475	1,780 New	1,780 $298,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $200,564 - $236,054	-2,600 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $202,409 - $249,626	2,600 New	2,600 $220,000

3,995

1.29B

18.2M

13.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital Advisors LP with notifications on news.